Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Cancer Heterogeneity and Plasticity
|
October 17, 2025
Cell Cycle Plasticity and Heterogeneity: An Underappreciated Feature of Cancer and Treatment Response
Erik S Knudsen, Thomas N O'Connor, Agnieszka K Witkiewicz
Cancers
|
May 11, 2024
Real-World Experience among Elderly Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitor-Based Therapy
Thomas N O'Connor, Emily Schultz, Jianxin Wang, et al.
Oncogene
|
February 26, 2025
Using prognostic signatures and machine learning to identify core features associated with response to CDK4/6 inhibitor-based therapy in metastatic breast cancer
Agnieszka K Witkiewicz, Jianxin Wang, Emily Schultz, et al.
JCO Precision Oncology
|
January 23, 2026
Real-World Plasma Thymidine Kinase Activity in High-Risk and Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Treated With Cyclin-Dependent Kinase 4/6 Inhibitors
Thomas N O'Connor, Emily Schultz, Sheheryar Kabraji, et al.
Oncogenesis
|
April 24, 2026
Cyclin E modulates vulnerability to CDC7 kinase inhibition
Adam P Dommer, Robert Kyne, Jianxin Wang, et al.
Molecular Cancer Therapeutics
|
August 16, 2024
Separable Cell Cycle Arrest and Immune Response Elicited through Pharmacological CDK4/6 and MEK Inhibition in RASmut Disease Models
Jin Wu, Jianxin Wang, Thomas N O'Connor, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
November 16, 2023
Cortical microglia dynamics are conserved during voluntary wheel running
Alexandra O Strohm, Thomas N O'Connor, Sadie Oldfield, et al.
NPJ Breast Cancer
|
December 1, 2025
Intrinsic RB activation induces tumoral and stromal anti-tumor responses that limit triple-negative breast cancer
Yin Wan, Jianxin Wang, Thomas N O'Connor, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 28, 2024
Compound heterozygous RYR1-RM mouse model reveals disease pathomechanisms and muscle adaptations to promote postnatal survival
Chen Liang, Sundeep Malik, Miao He, et al.
Cancer Research
|
February 13, 2025
Tumor Suppressors Condition Differential Responses to the Selective CDK2 Inhibitor BLU-222
Adam P Dommer, Vishnu Kumarasamy, Jianxin Wang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Cancer Heterogeneity and Plasticity
|
October 17, 2025
Cell Cycle Plasticity and Heterogeneity: An Underappreciated Feature of Cancer and Treatment Response
Erik S Knudsen, Thomas N O'Connor, Agnieszka K Witkiewicz
Cancers
|
May 11, 2024
Real-World Experience among Elderly Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitor-Based Therapy
Thomas N O'Connor, Emily Schultz, Jianxin Wang, et al.
Oncogene
|
February 26, 2025
Using prognostic signatures and machine learning to identify core features associated with response to CDK4/6 inhibitor-based therapy in metastatic breast cancer
Agnieszka K Witkiewicz, Jianxin Wang, Emily Schultz, et al.
JCO Precision Oncology
|
January 23, 2026
Real-World Plasma Thymidine Kinase Activity in High-Risk and Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Treated With Cyclin-Dependent Kinase 4/6 Inhibitors
Thomas N O'Connor, Emily Schultz, Sheheryar Kabraji, et al.
Oncogenesis
|
April 24, 2026
Cyclin E modulates vulnerability to CDC7 kinase inhibition
Adam P Dommer, Robert Kyne, Jianxin Wang, et al.
Molecular Cancer Therapeutics
|
August 16, 2024
Separable Cell Cycle Arrest and Immune Response Elicited through Pharmacological CDK4/6 and MEK Inhibition in RASmut Disease Models
Jin Wu, Jianxin Wang, Thomas N O'Connor, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
November 16, 2023
Cortical microglia dynamics are conserved during voluntary wheel running
Alexandra O Strohm, Thomas N O'Connor, Sadie Oldfield, et al.
NPJ Breast Cancer
|
December 1, 2025
Intrinsic RB activation induces tumoral and stromal anti-tumor responses that limit triple-negative breast cancer
Yin Wan, Jianxin Wang, Thomas N O'Connor, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 28, 2024
Compound heterozygous RYR1-RM mouse model reveals disease pathomechanisms and muscle adaptations to promote postnatal survival
Chen Liang, Sundeep Malik, Miao He, et al.
Cancer Research
|
February 13, 2025
Tumor Suppressors Condition Differential Responses to the Selective CDK2 Inhibitor BLU-222
Adam P Dommer, Vishnu Kumarasamy, Jianxin Wang, et al.
Page
of 2